News

30 Sep Nordion welcomes Milestone Funding from National Nuclear Security Administration to Advance New Source of Medical Isotopes

Nordion welcomes Milestone Funding from National Nuclear Security Administration to Advance New Source of Medical Isotopes

Funding supports Nordion’s collaboration with General Atomics and the University of Missouri Research Reactor Center to produce a new, reliable source of medical isotopes

OTTAWA, Canada, September 30, 2015 – Nordion, a standalone business within Sterigenics International, welcomes today’s announcement by the United States Department of Energy’s (DOE) National Nuclear Security Administration (NNSA) to award $9.7M…

30 Sep We are proud to announce the decision from the Canadian Nuclear Safety Commission (CNSC) to renew the Nuclear Substance Processing Facility Operating License for Nordion’s Class 1B nuclear substance processing facility in Ottawa, Ontario

Nordion welcomes 10 year operating license renewal

Canadian Nuclear Safety Commission approves ten-year license renewal for Ottawa, Ontario
nuclear substance processing facility

OTTAWA, Canada, September 30, 2015 — Nordion, a standalone business within Sterigenics International, today welcomed the Canadian Nuclear Safety Commission (CNSC) decision to renew the Nuclear Substance Processing Facility Operating License for the company’s Class 1B nuclear substance processing facility in Ottawa, Ontario…

20 Feb A landmark partnership to establish a new, reliable supply of medical isotopes

Sterigenics International and Nordion announce landmark Canada-U.S. partnership agreement to provide a long-term, reliable supply of medical isotopes

New medical isotope supply agreements with U.S.-based MURR and General Atomics will serve patients in Canada, the U.S. and around the world.

OTTAWA (Feb 20, 2015) – – Sterigenics International LLC and subsidiary Nordion, announced today agreements with General Atomics and the University of Missouri Research Reactor Center (MURR^®) to establish a new, reliable supply of medical isotopes…

14 Nov Nordion and Bruce Power sign long term contract to supply Cobalt-60 for clean, safe hospitals

Cobalt-60 is used to sterilize 40 per cent of the world’s single-use medical products and equipment

OTTAWA, November 14, 2014 – Nordion, a business unit of Sterigenics International LLC, is pleased to announce it has signed a multi-year agreement up to an additional 14-years with long-time partner Bruce Power…

06 Aug Nordion Announces Completion of Acquisition by Sterigenics International

OTTAWA, Ontario–(BUSINESS WIRE)–Aug. 6, 2014 — Nordion Inc. (TSX:NDN) (NYSE:NDZ), a leading provider of products and services to the global health science market, announced today the successful completion of the previously announced plan of arrangement (the “Arrangement”) and all of the outstanding common shares of Nordion have been acquired by an affiliate of Sterigenics International LLC (“Sterigenics”)…

01 Aug Nordion Receives Investment Canada Act Approval and Announces Expected Closing Date for Acquisition by Sterigenics

OTTAWA, Ontario–(BUSINESS WIRE)–Aug. 1, 2014 — Nordion Inc. (TSX:NDN) (NYSE:NDZ) announced today that the Minister of Industry has approved the previously announced proposed acquisition of all the common shares of Nordion Inc. by Sterigenics, pursuant to the terms of the Investment Canada Act. This approval was the last regulatory approval required for the proposed acquisition…

11 Jul Nordion Announces Termination of Hart-Scott-Rodino Act Waiting Period and Receipt of No-Action Letter for Acquisition by Sterigenics

OTTAWA, Canada–(BUSINESS WIRE)–Jul. 11, 2014 — Nordion Inc. (TSX:NDN) (NYSE:NDZ) announced that on July 10, 2014 the Federal Trade Commission terminated the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”) with respect to Sterigenics’ proposed acquisition of Nordion and the Canadian Competition Bureau issued a no-action letter pursuant to the Competition Act. The receipt of a no-action letter confirms that the Commissioner of Competition does not intend to challenge the proposed acquisition…

27 Jun Nordion Receives Second Request Under Hart-Scott-Rodino Act

OTTAWA, Ontario–(BUSINESS WIRE)–Jun. 27, 2014 — Nordion Inc. (TSX:NDN) (NYSE:NDZ) announced today that it and Sterigenics International LLC (“Sterigenics”) have each received a request for additional information (a “Second Request”) from the Federal Trade Commission (the “FTC”) under the Hart-Scott-Rodino Antitrust Improvements Act of 1976…

19 Jun Nordion Announces the Coming into Force of Legislative Amendments to the Nordion Act

OTTAWA, Ontario–(BUSINESS WIRE)–Jun. 19, 2014 — Nordion Inc. (TSX:NDN) (NYSE:NDZ) was advised today that the Parliament of Canada has enacted legislation affecting foreign ownership restrictions and limitations contained in the Nordion and Theratronics Divestiture Authorization Act (the “Nordion Act ”)…

11 Jun Nordion Receives Final Court Approval for Acquisition by Sterigenics

OTTAWA, Ontario–(BUSINESS WIRE)–Jun. 11, 2014 — Nordion Inc. (TSX:NDN) (NYSE:NDZ) announced today that the Ontario Superior Court of Justice (Commercial List) has issued a final order approving the previously announced plan of arrangement providing for the proposed acquisition by Sterigenics of all the issued and outstanding common shares of Nordion for cash consideration of US$13.00 per share (the “Arrangement”)…